Oral min to topical? Dut to fin?
    Minoxidil 1/23/2026

    From the encyclopedia
    Dutasteride →

    Heavy duty finasteride that comes with higher risks

    Minoxidil →

    An essential vasodilator with some anti-androgenic effects

    Finasteride →

    Frontline, gold standard treatment for combatting androgenic alopecia

    At a glance
    In this treatment experience post, the primary subjects mentioned are
    💊 Dutasteride (oral) 0.5mg 4 years
    💊 Minoxidil (oral) 5mg 3 years
    💧 Minoxidil (topical)
    💊 Finasteride (oral)
    💧 Nizoral (topical) 1x weekly
    the tone is 😐 neutral with some growth results.

    Other terms

    The user is considering switching from oral to topical minoxidil and possibly adding finasteride, while continuing with dutasteride and incorporating microneedling to improve hair loss treatment. They are concerned about potential shedding during the transition.
    View this post in the Community →

    Similar Community Posts Join

    6 / 6 results

    Related Research

    6 / 6 results
      Managing Patterned Hair Loss – A Hair Raising Task!

      research Managing patterned hair loss – a hair raising task!

      October 2021 in “Cosmoderma”
      This review summarizes existing knowledge on diffuse and patterned alopecia, emphasizing recent advancements in treatment beyond FDA-approved options, but it reports no new clinical findings.
      A Review of the Treatment of Male Pattern Hair Loss

      research A review of the treatment of male pattern hair loss

      53 citations , February 2020 in “Expert Opinion on Pharmacotherapy”
      This review discusses pharmacologic and non-pharmacologic treatments for androgenetic alopecia, noting that current medications like finasteride and minoxidil can slow hair loss but only partially restore hair growth, with early treatment offering better outcomes.
      Androgenetic Alopecia: Therapy Update

      research Androgenetic Alopecia: Therapy Update

      May 2023 in “Drugs”
      This comprehensive review analyzes androgenetic alopecia treatments, discussing the mechanisms, costs, efficacy, and safety of FDA-approved drugs like minoxidil and finasteride, as well as newer non-FDA-approved options that have shown effectiveness across various studies.
      Safety Concerns When Using Novel Medications to Treat Alopecia

      research Safety concerns when using novel medications to treat alopecia

      23 citations , October 2018 in “Expert Opinion on Drug Safety”
      This review discusses the safety concerns associated with new treatments for non-scarring alopecias, highlighting that while these therapies such as JAK inhibitors and oral minoxidil show efficacy in hair regrowth, their safety profiles vary significantly, requiring careful consideration of benefits and risks.

      research Male androgenetic alopecia

      January 2025 in “Anais Brasileiros de Dermatologia”
      This review examines male androgenetic alopecia and reports no new clinical results, offering insights to aid dermatologists in making informed therapeutic decisions.